PRESS RELEASE published on 10/30/2023 at 06:00, 3 years ago Biophytis and Innovation Solutions Pharma sign a partnership agreement to accelerate market access for Sarconeos (BIO101) in Brazil
REGULATED PRESS RELEASE published on 10/30/2023 at 06:00, 3 years ago Biophytis and Innovation Solutions Pharma sign a partnership agreement to accelerate market access for Sarconeos (BIO101) in Brazil
REGULATED PRESS RELEASE published on 10/30/2023 at 06:00, 3 years ago Biophytis et Innovation Solutions Pharma signent un partenariat en vue d’accélérer l’accès au marché de Sarconeos (BIO101) au Brésil
PRESS RELEASE published on 10/27/2023 at 23:00, 3 years ago Biophytis receives notice of delisting from Nasdaq and announces it will request a hearing before the Nasdaq Hearings Panel
PRESS RELEASE published on 10/27/2023 at 23:00, 3 years ago Biophytis reçoit un avis de radiation du Nasdaq et annonce qu’elle fera appel de cette décision auprès du Comité d’Audience du Nasdaq
REGULATED PRESS RELEASE published on 10/27/2023 at 23:00, 3 years ago Biophytis reçoit un avis de radiation du Nasdaq et annonce qu’elle fera appel de cette décision auprès du Comité d’Audience du Nasdaq
REGULATED PRESS RELEASE published on 10/27/2023 at 23:00, 3 years ago Biophytis receives notice of delisting from Nasdaq and announces it will request a hearing before the Nasdaq Hearings Panel
REGULATED PRESS RELEASE published on 10/23/2023 at 07:00, 3 years ago Biophytis announces the launch of a rights issue with maintenance of shareholders’ preferential subscription rights to continue the execution of its strategic roadmap
REGULATED PRESS RELEASE published on 10/23/2023 at 07:00, 3 years ago Biophytis annonce le lancement d’une augmentation de capital sous forme d’émission d’ABSAR avec maintien du droit préférentiel de souscription des actionnaires afin de poursuivre l’exécution de sa feuille de route stratégique
PRESS RELEASE published on 09/27/2023 at 23:15, 3 years 1 month ago Biophytis publie ses comptes semestriels au 30 juin 2023 et fait le point sur ses activités
Published on 11/06/2026 at 22:15, 2 days 6 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 15 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 16 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 16 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 01:55, 3 hours 1 minute ago EQS-Adhoc: NEXTDC Limited: Response to Statement by Goodman Group & Digital Realty
Published on 11/08/2026 at 12:10, 16 hours 46 minutes ago GSMA MWC26 Doha opens with call to align on global industry standards and close MENA's connectivity gap
Published on 11/08/2026 at 10:15, 18 hours 41 minutes ago 2026 China International Intelligent Communication Forum Held in Wuxi
Published on 11/07/2026 at 13:35, 1 day 15 hours ago Eurobattery Minerals board member and CEO remanded in custody in Sweden
Published on 11/06/2026 at 20:15, 2 days 8 hours ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 19:06, 2 days 9 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 2 days 9 hours ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 2 days 9 hours ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 2 days 9 hours ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
